is synthesized in the cytosol and imported into the mitochondrial matrix, where it is activated and functions as the primary antioxidant for cellular respiration. The specific mechanisms that target SOD-2 to the mitochondria remain unclear. We hypothesize that inducible heat shock protein 70 (iHSP70) targets SOD-2 to the mitochondria via a mechanism facilitated by ATP, and this process is impaired in persistent pulmonary hypertension of the newborn (PPHN). We observed that iHSP70 interacts with SOD-2 and targets SOD-2 to the mitochondria. Interruption of iHSP70-SOD-2 interaction with 2-phenylethylenesulfonamide-(PFT-, a specific inhibitor of substrate binding to iHSP70 COOH terminus) and siRNA-mediated knockdown of iHSP70 expression disrupted SOD-2 transport to mitochondria. Increasing intracellular ATP levels by stimulation of respiration with CaCl 2 facilitated the mitochondrial import of SOD-2, increased SOD-2 activity, and decreased the mitochondrial superoxide (O 2 ·Ϫ ) levels in PPHN pulmonary artery endothelial cells (PAEC) by promoting iHSP70-SOD-2 dissociation at the outer mitochondrial membrane. In contrast, oligomycin, an inhibitor of mitochondrial ATPase, decreased SOD-2 expression and activity and increased O 2 ·Ϫ levels in the mitochondria of control PAEC. The basal ATP levels and degree of iHSP70-SOD-2 dissociation were lower in PPHN PAEC and lead to increased SOD-2 degradation in cytosol. In normal pulmonary arteries (PA), PFT-impaired the relaxation response of PA rings in response to nitric oxide (NO) donor, S-nitroso-N-acetyl-penicillamine. Pretreatment with Mito-Q, a mitochondrial targeted O 2 ·Ϫ scavenger, restored the relaxation response in PA rings pretreated with PFT-. Our observations suggest that iHSP70 chaperones SOD-2 to the mitochondria. Impaired SOD-2-iHSP70 dissociation decreases SOD-2 import and contributes to mitochondrial oxidative stress in PPHN.
persistent pulmonary hypertension of the newborn; pulmonary artery endothelium; oxidative stress; vasodilation; nitric oxide OXIDATIVE STRESS PLAYS A KEY ROLE in the pathogenesis of pulmonary hypertension (14, 41a) . Persistent pulmonary hypertension of the newborn (PPHN) is associated with increased generation of reactive oxygen species (ROS), including superoxide radical (O 2 ·Ϫ ) (10) . ROS induces pulmonary vascular remodeling, which leads to increased vascular resistance and impaired pulmonary vasodilation in PPHN (46) . Studies in a fetal lamb model of PPHN induced by prenatal constriction of the ductus arteriosus have previously identified increased NA-DPH oxidase activity and uncoupling of endothelial nitric oxide synthase (eNOS) as the major sources of O 2 ·Ϫ in the cytosol (10, 33, 36) . Mitochondria are the major source of cellular O 2 ·Ϫ , producing approximately five to ten times more O 2 ·Ϫ than the cytosolic sources (15) . The role of mitochondria as a major source of O 2 ·Ϫ in PPHN remains unclear. The reactive O 2 ·Ϫ is produced in the mitochondria by transfer of a single electron to molecular oxygen (O 2 ) during oxidative phosphorylation and, when in excess, can damage cell components such as proteins, lipids, and DNA and can also impair mitochondrial bioenergetics (44) . Exposure to high O 2 concentrations can increase O 2 ·Ϫ generation in the mitochondria, which in turn plays a major role in the toxicity of hyperoxia (44) . Newborns are at risk of experiencing oxidative stress because O 2 concentrations increase by several times at birth compared with in utero environment. Adaptive increases in cellular antioxidant defenses, particularly superoxide dismutases (SODs), during this transition protect endothelial cells from the potential increases in O 2 ·Ϫ and oxidative stress (21, 24) . Mitochondrial-localized SOD (MnSOD, SOD-2) is the most important of the three SOD isoforms in the cell for air-breathing mammals (37) . Our previous studies demonstrated a decrease in SOD-2 expression and an increase in mitochondrial O 2 ·Ϫ in pulmonary artery (PA) endothelial cells (PAEC) in PPHN (2) . The mechanism of decreased SOD-2 expression in the mitochondria of pulmonary endothelium in PPHN remains unclear and is the subject of our present studies.
SOD-2 is synthesized in the cytosol as a precursor with a cleavable polypeptide leader sequence at the amino terminus, which appears to target it to the mitochondria (4, 25) . To reach mitochondrial matrix, SOD-2 must pass through translocases on the outer membrane and the inner membrane (31, 40) . In the matrix, the mitochondrial-targeting sequence is normally cleaved, and mature SOD-2 is assembled into the active homotetramer by the mitochondrial peptidase (50) . Newly synthesized proteins in the cytosol destined to mitochondria interact with chaperones in the cytosol, which include HSP90 and HSP70 (18, 27, 38, 45, 51) . Previous studies have shown that the activity of both SOD-1 and SOD-2 was significantly decreased in HSP70.1 knockout mice compared with the wildtype littermates (17) . However, the nature of this interaction between SOD-2 and its chaperone remains unknown.
In mammalian cells, more than eight members of HSP70 family have been identified and classified according to their molecular weights and compartment in which they reside. These include constitutive cytoplasmic forms called HSP70 (HSP70, 70 kDa, HSP73, HSPA8), inducible forms (iHSP70, 72 kDa, HSPA1A/A1B), mitochondrial form (mt-HSP70, 75 kDa), and the endoplasmic reticulum-localized protein called GRP78 (13, 19, 41) . In the normal or "unstressed" cells, iHSP70 levels are barely detectable; however, in the presence of physiological or exogenous stressors, iHSP70 is rapidly upregulated (26) . Their functions are critical for cell survival, including proper protein refolding, cellular localization, refolding of misfolded protein, and assembly of several client proteins (41) . HSP70 is also involved in the refolding of denatured proteins and transport of folded proteins for degradation (18, 30) . HSP70/HSC70 also act as a key cochaperone for HSP90. The cellular actions of iHSP70 are mediated mainly by its dynamic physical interaction with its client proteins and other cochaperones (13) . HSP70 possesses an NH 2 -terminal ATPase domain and a COOH-terminal domain that binds a specific segment of the client proteins. Binding of ATP to HSP70 NH 2 terminus decreases the affinity of protein-binding domain to client proteins and promotes fast on and off release of protein (38) . Hydrolysis of ATP to ADP leads to conformational changes in both domains and stabilizes the interaction with the substrate (3) . At the outer mitochondrial membrane (OMM), iHSP70-substrate complex must dissociate to enable translocating protein to dock on the translocon of OMM. At the inner mitochondrial membrane (IMM), the import motor machinery in which mt-HSP70 forms its core and the membrane potential of the inner membrane transfer proteins into the matrix (35, 49) .
The aim of our present study is to investigate the mechanisms involved in the mitochondrial import of SOD-2 and the mechanisms of decreased SOD-2 levels in the mitochondria of PPHN-PAEC that we previously reported (2) . We investigated the hypothesis that iHSP70 chaperones SOD-2 to the mitochondria and that intracellular ATP facilitates SOD-2-iHSP70 dissociation at the OMM and SOD-2 import to the mitochondria. Furthermore, we hypothesized that, in PPHN, mitochondrial import of SOD-2 is impaired due to decreased ATP levels and contributes to increased oxidative stress and impaired PA relaxation. Studies were done in PAEC and PA segments isolated from fetal lambs with PPHN or control lambs.
MATERIALS AND METHODS
Antibodies and chemicals. Rabbit anti-SOD-2 (1:10,000) was obtained from Assay Designs-Enzo Life Science (Ann Arbor, MI). Rabbit anti-proinhibitin-2 (1:10,000) or rabbit anti-iHSP70 (1:5,000) or rabbit anti-mtHSP70 (1:1,000) and siRNA against iHSP70 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). 2-Phenylethylenesulfonamide-mu (PFT-), calcium chloride (CaCl 2), exogenous ATP, and oligomycin were obtained from Sigma Aldrich (St. Louis, MO). Pierce mitochondrial isolation kit was from Thermo Scientific (Rockford, IL). All other reagents were obtained from Life Science Technology-Invitrogen (Carlsbad, CA).
Creation of PPHN lamb model. This study was approved by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin and conformed to NIH guidelines for animal use in research. Constriction of fetal ductus arteriosus was performed at 128 Ϯ 2 days of gestation (term ϭ 144 days) as we described previously (33, 34) . Control fetal lambs had thoracotomy performed without constriction of the ductus arteriosus. After 8 days of ductal constriction, fetal lungs were harvested for the isolation of PA and PAEC.
Cell culture. PAECs were isolated and characterized using techniques we described previously (33, 34) . PAEC isolated from control (normal) and hypertensive fetal lambs were cultured in DMEM with 20% FCS at 37°C in room air and 5% CO 2. We used PAEC between passages 2 and 4 for our experiments. Because the cytotoxic effect of PFT-is increased apoptosis from impaired mitochondrial localization of p53 (13), we predetermined the appropriate dose of PFT-in preliminary experiments by examining the toxicity of varying doses of PFT-on cell viability. We found that PFT-at 5 M concentration produced optimal effects with no difference in apoptosis between DMSO-treated control and PFT--treated cells (data not shown), and therefore 5 M PFT-was used for the reminder of our experiments.
Mitochondrial isolation and study. Mitochondria were isolated and purified using the Pierce mitochondrial isolation kit (Thermo Scientific) as described previously (2) . Mitochondrial respiration was measured using Oroboros high-resolution instrument (Innsbruck, Austria) with Clarke-type electrode to verify that the isolated mitochondria were intact and functional. The respiratory control ratio (ICI) with pyruvate/malate was ϳ5.2, indicating intactness of the IMM. Mitochondrial H 2O2 was measured using Amplex-red assay (Invitrogen), and the absorbance was read at 560 nm using microplate reader (FLUOstar Omega by BMG LabTech, Durham, NC). Production of mitochondrial O 2 ·Ϫ was visualized in intact cultured PAEC using a mitochondrial-targeted dihydroethidium (Mito-HE) fluorescence probe (MitoSOX, Invitrogen; excitation/emission: 510/580 nm). The result obtained from fluorescence microscopy was verified using high-performance liquid chromatography (HPLC). Changes in mitochondrial subcellular localization of SOD-2 were measured using Western blots of cytosolic and mitochondrial fractions and by immunofluorescence method in the intact cells using SOD-2 polyclonal antibody tagged with fluorophore (Alexafluor 488 with conjugated anti-Rabbit IgG) followed by mitotracker with excitation/emissions of 488 and 568 nM.
Immunohistochemistry and histological analyses. After the delivery of control fetal lamb, apical lobe of the left lung was inflation fixed with buffered 10% formalin at 25 cmH2O pressure for histology after the lungs were flushed via the PA with 0.9% NaCl at 4°C. Lung tissue was formalin fixed, embedded in paraffin, and cut in 5-M sections. Sections were then deparaffinized in xylene for 5 min. Nonspecific antigen binding sites were blocked with serum (DOKA, Carpentaria, CA). Sections were then incubated in the mixture of two primary antibodies, rabbit polyclonal SOD-2, 1:400 (Assay Designs, Ann Arbor, MI) and mouse monoclonal iHSP70, 1:200 (Enzo Life Science, Ann Arbor, MI) antibodies overnight in 4°C. After being washed with PBS to remove the unbound antibodies, the slides were incubated in a mixture of two fluorescence-conjugated secondary antibodies (FITCconjugated horse anti-mouse and Texas Red-conjugated goat antirabbit). Slides were coverslipped with fluorescent mounting medium and visualized under fluorescence microscopy for analysis.
Assessment of SOD-2 interactions with iHSP70/mt-HSP70. SOD-2 interactions with cytosolic (iHSP70) and mitochondrial (mt-HSP70) chaperones were assessed in lung tissue using immunohistochemistry as described above and in cell fractions using immunoprecipitation method as previously described (2). SOD-2 was immunoprecipitated from cytosolic and mitochondrial fractions of PAEC or lung tissue. The immunoprecipitate was blotted for SOD-2, iHSP70/mtHSP70 to delineate the association of these proteins. PAEC were incubated with either HBSS alone as control or HBSS containing 10 M CaCl2 in double distilled water for 30 min to stimulate de novo mitochondrial ATP synthesis (42), or 10 M ATP was added directly to cell lysates containing cytosolic proteins and intact mitochondria and incubated for 15 min.
Inhibition of SOD2-iHSP70 interaction. iHSP70 chaperone function can be altered functionally by blocking iHSP70 interaction with the client protein or quantitatively by reducing iHSP70 expression, making it less available for interaction. We employed both methods to validate the inhibition of SOD2-iHSP70 interaction and study the role of iHSP70 as the chaperone for SOD-2. For the first approach, we used PFT-(Sigma Aldrich), a small molecule that specifically inhibits the substrate protein binding to iHSP70 COOH-terminal substrate-binding domain to decrease SOD-2 association with iHSP70. Proliferating, control PAECs were incubated with 5 M PFT-dissolved in DMSO over 18 h as reported previously (43) . DMSO-treated control PAEC were used as a control. At 90% confluence, PAECs were harvested and cell lysate was obtained for the study. In our preliminary studies, we verified that the effect of PFTon SOD-2 function is not attributable to suppression of iHSP70 expression. We observed no change in iHSP70 protein levels between DMSO-treated control and PFT--treated cells (Fig. 5A ). We then studied the effects of iHSP70-SOD-2 inhibition on mitochondrial O 2 ·Ϫ , SOD-2 protein levels in the mitochondria, iHSP70-SOD-2 association in the cytosolic fraction, and SOD2 activity. For the second approach, we used small-interfering RNA (siRNA, Santa Cruz Biotechnology) to knockdown iHSP70 expression and validate the effect of PFT-on iHSP70-SOD-2 interaction. For these studies, control PAEC were seeded in antibiotic-free medium supplemented with 20% FBS. Cells were incubated at 37°C in a CO 2 incubator until they were 60 -80% confluent. Solution A for transfection was prepared by diluting 6 l of siRNA duplex (sc-270418) with 100 l siRNA transfection medium (sc-36868). Solution B was made by diluting 6 l of siRNA transfection reagent (sc-29528) with 100 l siRNA transfection medium (sc-36868). PAECs were washed once with 2 ml of siRNA transfection medium (sc-36868), and the mixture of solutions A and B was overlaid on the washed PAECs, which were incubated for 6 h at 37°C in a CO 2 incubator. Control siRNA (sc-37007) or fluorescein-conjugated scrambled sequence siRNA (sc-36869) for immunofluorescence studies were used as negative controls. After 6-h incubation, medium was replaced with 1 ml of fresh normal growth medium, and cells were incubated for an additional 24 h. Medium was then replaced with fresh 1ϫ normal growth medium and incubated for another 24 h before the cells were used for experiments.
Measurement of mitochondrial O2 ·Ϫ . We used Mito-HE (MitoSOX, Molecular Probe, Sigma) to quantify O2 ·Ϫ levels in the mitochondria. Because Mito-HE produces both O2 ·Ϫ -specific (2-OHMito-E ϩ ) and -nonspecific (Mito-E ϩ ) products that can produce fluorescence, we used two complementary methods to assess mitochondrial O2 ·Ϫ levels. 1) Mito-HE (MitoSOX) epifluorescence was used. PAECs were grown to 40 -50% confluence in eight-well chamber slides. Cells in selected wells were transduced with siRNA against iHSP70 (bovine, Santa Cruz Biotechnology) or incubated with 5 M PFT-or 10 M oligomycin or 10 M CaCl2. Cells treated with 1 M Antimycin A (complex III inhibitor, Sigma) served as a positive control. Polyethylene glycol (PEG)-SOD (100 U/ml) was used to quench the signal produced by Antimycin A to verify specificity of fluorescence signal for O2 ·Ϫ . Phorbol 12-myristate 13-acetate (10 M) (PMA, an activator of NADPH oxidase activity, Sigma), which is expected to increase cytosolic and not mitochondrial O2 ·Ϫ formation, served as a negative control. After treatments, cells were incubated with 10 M Mito-HE for 30 min to detect mitochondrial O2 ·Ϫ levels as described previously (2) . Fluorescence signals were quantified using fluorescence detection microscopy and analyzed with MetaView software. 2) We also verified changes in O2 ·Ϫ levels using HPLC (Beckman HPLC system Gold model with a C-18 reversephase column; Nucleosil 250, 4.5 mm; Sigma-Aldrich) method to quantify the O 2 Ϫ -specific fluorescent product of Mito-HE (2-OH-Mito-E ϩ ). Confluent cells in 100-mm culture dishes were incubated with HBSS ϩ DMSO as control, 5 M PFT-, 10 M oligomycin, iHsp70 siRNA, or 10 M CaCl2. We used PMA and Antimycin A as negative and positive controls for mitochondrial O 2 Ϫ . Cells were incubated in medium containing 10 M Mito-HE for 30 min. Incubation was stopped by washing the cells with ice-cold DPBS buffer. PAECs were then scraped into 1 ml of cold DPBS and pelleted by centrifuging at 1,000 g for 5 min. The resultant pellet was resuspended in 200 l of 0.25% Triton X-100 and fractured using insulin syringe. HPLC was performed using Agilent 1100 system as previously described (32).
2-OH-Mito-E
ϩ was normalized to protein concentrations measured by bicinchoninic acid (BCA) method.
In vitro relaxation response of PA rings. Control fetal lambs (135-day gestation) were euthanized, and their lungs were harvested. Third-to fifth-generation PA branches were cut into 3-mm long rings with 400 -600-m internal diameter and incubated with 5 M PFTor buffer with DMSO for 18 h at 37°C in room air and 5% CO 2. After incubation, excess PFT-or DMSO was removed, and treated PA rings were incubated in 2-ml tissue baths, where the pH and PO2 were normalized for all rings. PA ring tension was measured by wire myography using standard techniques, as we described previously (2, 33, 34) . PA rings were preconstricted with 10 Ϫ7 M norepinephrine, and the relaxation response to log doses of ATP (a NOS agonist) and/or S-nitroso-N-acetyl-penicillamine (SNAP, an Ṅ O donor) in the presence/absence of 10 Ϫ12 M Mito-Q (a mitochondrial-targeted O2 ·Ϫ scavenger) were measured. Measurement of SOD-2 activity. PAECs were grown in six-well plates and then incubated with 5 M PFT-dissolved in DMSO, 10 M oligomycin, or HBSS Ϯ DMSO as control and after siRNA transfection. Cell lysates were treated with ATP with doses ranging from 10 Ϫ6 -10 Ϫ3 M, and SOD-2 activity was quantified using colorimetric method as described previously (2) . SOD-2-specific activity was obtained by treatment of cell lysates with potassium cyanide (KCN) to inhibit cytosolic and extracellular SOD isoforms. One unit of SOD activity was defined as the amount of enzyme needed to exhibit 50% dismutation of the O 2 ·Ϫ , and SOD-2 activity was corrected against protein concentration in each well measured using BCA method.
Adenine nucleotide quantification. Intracellular adenine nucleotides (ATP, ADP, and AMP) in control and PPHN PAEC were analyzed using HPLC following acid extraction. HPLC analysis of nucleotides was performed on Kinetex C-18 column per methods previously described (5) . ATP, ADP, and AMP peaks were measured for each sample, compared with standards, and expressed in nanomoles/milligrams of protein.
Assessment of SOD-2 degradation. We assessed SOD-2 degradation by quantifying ubiquitinated fraction of total SOD-2 protein in PAEC. Polyubiquitinated SOD-2 was quantified using ubiquitin enrichment kit (Thermo-Scientific). Cytosolic proteins (100 g) from both control and PPHN PAEC were incubated with 20 l ubiquitin affinity resin for 2 h at 4°C. SOD-2 was then immunoprecipitated in the lysate using polyclonal SOD-2 antibodies. The eluted ubiquitinated protein was separated by SDS-PAGE and blotted with SOD-2 polyclonal antibody and antiubiquitin antisera. The ratio of ubiquitinated SOD-2 to SOD-2 was calculated for comparison between control and PAEC samples.
Statistics. Data are shown as means Ϯ SE. Student's t-test was used for normally distributed data, and Mann-Whitney U-test was used for data that did not pass the normality test for comparison between two groups. One-way ANOVA with Student-Newman-Keuls post hoc test was used when more than two groups were compared. Data were analyzed with GraphPad Prism (GraphPad, La Jolla, CA). A P value Ͻ0.05 was considered significant.
RESULTS
SOD2 interacts with iHSP70. SOD-2 colocalizes with iHSP70 in the lungs of control fetal lambs (Fig. 1A) . We observed a widespread colocalization of SOD-2 and iHSP70 in airway epithelial cells, alveoli, vascular endothelium, and walls of pulmonary vessels. We further confirmed SOD2-iHSP70 association using the coimmunoprecipitation method. We observed higher levels of iHSP70 and SOD-2 immunoprecipitated from cytosol of PAEC (Fig. 1B) and also in pulmonary artery homogenates of PPHN lambs (Fig. 1C) compared with controls. However, we found no significant difference in SOD2-iHSP70 association between the whole lung homogenates of control and PPHN lambs (Fig. 1C) . The baseline protein levels of iHSP70, determined by Western blot, were higher in PPHN-pulmonary artery homogenates compared with controls (Fig. 1D) . We also observed SOD2-iHSP70 association in other cell types including bovine aortic endothelial cells and fetal aortic endothelial cells (data not shown). iHSP70 is one of the stress response proteins induced in the presence of ROS (10, 16, 26) . Therefore, higher levels of iHSP70 expression and SOD2-iHSP70 association in PPHN may indicate an adaptive response to oxidative stress.
Inhibition of SOD2-iHSP70 interaction disrupts SOD-2 transport to mitochondria. We assessed the biological function of iHSP70 in relation to the mitochondrial import of SOD-2 by interrupting SOD2-iHSP70 interaction. Compared with untreated controls, PFT-treatment decreased mitochondrial SOD-2 protein levels ( Fig. 2A) , without decreasing the baseline expression of iHSP70 (Fig. 2B) . We verified the PFT-effects on SOD-2 import by depleting iHSP70 protein using siRNA directed to iHSP70. iHSP70 knockdown also decreased SOD-2 in the mitochondria by greater than twofold (Fig. 2C) . In the immune-colocalization studies, the siRNA decreased the green fluorescence signals by greater than twofold in the mitochondria of intact cells compared with negative control (Fig. 2D) . siRNA decreased iHSP70 expression by 60% in our studies (Fig. 2E) . These results indicate that iHSP70 targets SOD-2 to the mitochondria.
Role of iHSP70 in the regulation of mitochondrial oxidative stress. We observed that PFT-disrupted mitochondrial import of SOD-2 by decreasing SOD2-iHSP70 association in the cytosol in treated cells when compared with DMSO-treated control (Fig. 3A) . The downstream effect of decreased SOD-2 in the mitochondria is increased mitochondrial O 2 ·Ϫ levels. We assessed the mitochondrial O 2 ·Ϫ generation following interruption of SOD2-iHSP70 interaction using mito-HE (MitoSOX). Mito-HE fluorescence was increased in Antimycin A-treated control PAEC, whereas PEG-SOD pretreatment decreased the signal (Fig. 3B) . Interruption of SOD2-iHSP70 interaction by PFT-and depletion of iHSP70 expression by siRNA knockdown increased MitoSOX fluorescence signals, respectively (Fig. 3C) . MitoSOX signal was higher in PPHN PAEC when compared with control; increasing de novo ATP synthesis by CaCl 2 treatment decreased MitoSOX fluorescein signals by greater than twofold (Fig. 3C ) in PPHN PAEC. We verified these epifluorescence results by performing HPLC measurement of O 2 ·Ϫ -specific MitoSOX oxidation product, 2-OHMito-E ϩ (Fig. 4A) . HPLC analysis showed that Antimycin A increased 2-OH-Mito-E ϩ level by approximately threefold, whereas PEG-SOD pretreatment decreased 2-OH-Mito-E ϩ level (positive control, Fig. 4A ). The level of 2-OH-Mito-E ϩ was not increased by PMA (negative control, Fig. 6A ). Increased mitochondrial O 2 ·Ϫ generation in control PAEC by . iHSP70 expression and SOD2-iHSP70 association were increased in persistent pulmonary hypertension of the newborn (PPHN). The SOD2-iHSP70 association, evaluated by ratio of iHSP70/SOD-2, was higher in PA endothelial cells (PAEC) cytosol (n ϭ 5, P Ͻ 0.05) (B) and PA homogenates (n ϭ 4, P Ͻ 0.05) (C) but not in whole lung (n ϭ 4, P ϭ 0.85) in PPHN. D: iHSP70 expression was increased in PPHN PA homogenates (n ϭ 4, P Ͻ 0.05). *P Ͻ 0.05 from corresponding controls.
PFT-, iHSP70 knockdown, and oligomycin was also validated by increased levels of 2-OH-Mito-E ϩ in Mito-HEtreated cells (Fig. 4B) . In PPHN PAEC, the baseline level of 2-OH-Mito-E ϩ was higher than control; however, increasing ATP levels following CaCl 2 treatment decreased 2-OHMito-E ϩ level (Fig. 4B ). (Fig. 4C) . Catalase pretreatment decreased H 2 O 2 detection by 90% in the mitochondria of PPHN PAEC incubated with CaCl 2 (data not shown). These data further support our concept that iHSP70 regulates SOD-2 function and mitochondrial oxidative stress.
Disruption of mitochondrial import of SOD-2 impairs PA relaxation. Previous studies have shown that extracellular ATP stimulates eNOS activity and Ṅ O release (7, 34). We investigated whether SOD-2 facilitates Ṅ O-mediated PA relaxation by regulating the oxidative stress in the vascular cells. We observed that disruption of mitochondrial import of SOD-2 by PFT-attenuated the dose-dependent relaxation responses of control PA to ATP and SNAP. Because HSP70 acts as a key cochaperone for HSP90 and previous studies have shown that HSP90-eNOS association increases eNOS activity (33), in our preliminary studies, we examined the effect of PFT-at 5 M dose on HSP90-eNOS association. PFT-has no direct effect on HSP90-eNOS association (data not shown). Decreasing mitochondrial O 2 ·Ϫ levels in the control PA by Mito-Q did not affect PA relaxation to either ATP or SNAP (data not shown). Pretreatment of PFT--treated vessels with Mito-Q improved PA relaxation response to ATP and SNAP (Fig. 5, A and B) . These data suggest that the decreased PA relaxation response was a result of increased mitochondrial O 2 ·Ϫ levels after disruption of mitochondrial import of SOD-2.
ATP regulates SOD2-iHSP70 interaction. ATP caused a dose-dependent increase in SOD-2 activity in PPHN-PAEC (Fig. 6A) . In contrast, inhibition of mitochondrial ATPase and ATP synthesis with oligomycin attenuated the SOD-2 activity in control PAEC. The attenuated SOD-2 activity by oligomycin was reversed by exogenous ATP treatment (Fig. 6B) . Furthermore, interruption of SOD2-iHSP70 interaction by PFT- (Fig. 6C) and iHSP70 knockdown (Fig. 6D) abolished ATP responses in control PAEC. We further elucidated the Fig. 2 . Effect of inhibition of SOD2-iHSP70 interaction by 2-phenylethylenesulfonamide-(PFT-) on mitochondrial SOD-2 levels (A), iHsp70 expression in cytosol (C), and effect of siRNA knockdown of iHSP70 on mitochondrial SOD-2 levels (C). Proinhibitin-2 was used as loading control for mitochondrial and ␤-actin for cytosolic fractions, respectively. A: incubation of control PAEC with 5 M PFT-for 18 h decreased SOD-2 levels in the mitochondria compared with untreated PAEC (n ϭ 5, P Ͻ 0.01). B: PFT-did not change the basal expression of iHSP70 in treated PAEC (n ϭ 5, P ϭ 0.7). C: siRNA knockdown of iHSP70 expression decreased SOD-2 protein levels in the mitochondria of control cells (n ϭ 3, P Ͻ 0.05). D: localization and quantification of SOD-2 in the mitochondria of intact cell following iHSP70 knockdown was assessed using double labeling and immunofluorescence method. Mitotracker red was used to label the mitochondria (a and d), FITC (green fluorescence) for SOD-2 (b and e), and merged pictures are represented by yellow color for localization of SOD-2 in the mitochondria (c and f). iHSP70 knockdown decreased fluorescence signals (e) and localization of SOD-2 to the mitochondria (f) when compared with negative control (b and c), (n ϭ 3, P Ͻ 0.05). E: siRNA decreased iHSP70 expression by 60% (n ϭ 3, P Ͻ 0.01), #P Ͻ 0.05 from control. IOD, integrated optical density.
mechanisms by which ATP increases SOD-2 activity by quantitative assessment of ATP effects on SOD2-iHSP70 interaction. Previous studies have shown that ATP promotes a transient interaction of client proteins with HSP70, favoring increased protein import into mitochondria (3). We observed that ATP increased SOD2-iHSP70 dissociation in the cytosol of PPHN-PAEC when compared with untreated PPHN-PAEC (Fig. 7A) . Translocation of SOD-2 from the OMM to the matrix requires the import motor machinery in the IMM that has mt-HSP70 at its core, surrounded by other cochaperones (49, 51) . ATP also increased SOD2-mtHSP70 association in the mitochondria of PPHN-PAEC significantly when compared with untreated control (Fig. 7B) . This was associated with increased SOD-2 protein levels in the mitochondria of ATP-treated PPHN PAEC (Fig. 7C) . In contrast, oligomycin decreased the basal mitochondrial SOD-2 levels by approximately threefold and by fourfold when compared with ATPstimulated SOD-2 levels in control (Fig. 7D) . These results together suggest that ATP increased SOD-2 activity by promoting SOD2-iHSP70 dissociation, facilitating SOD-2 import into the mitochondria.
Coupling of mitochondrial oxidative phosphorylation and ATP synthesis is depressed in PPHN. Respiration and ATP synthesis are coupled in normal mitochondria, with tight reg- ·Ϫ was also measured by high-performance liquid chromatography as the level of 2-OH-Mito-E ϩ to verify MitoSOX fluorescence. A: interruption of SOD2-iHSP70 interaction by 5 M PFT-, siRNA knockdown of iHSP70, and inhibition of mitochondrial ATPase activity with 10 M oligomycin increased 2-OH-Mito-E ϩ in PAEC. The baseline level of 2-OH-Mito-E ϩ in PPHN is higher than control. However, 10 M CaCl2 decreased 2-OH-Mito-E ϩ levels in PPHN PAEC (n ϭ 3, P Ͻ 0.05). B: effects of intracellular ATP and interruption of SOD2-iHSP70 interaction on H2O2 production. H2O2 release from mitochondria was measured using Amplex red-horseradish peroxidase reagent in intact mitochondria, isolated from PAEC. H2O2 detected was corrected against mitochondrial protein content. Interruption of SOD2-iHSP70 interaction by PFT-, depletion of iHSP70 protein by siRNA knockdown, and inhibition of mitochondrial ATPase activity by oligomycin decreased H2O2 formation and release from the mitochondria of control PAEC. C: H2O2 in PPHN is lower than control; however, treatment of PPHN PAEC with 10 M CaCl2 for 30 min increased H2O2 release from mitochondria of PPHN PAEC (n ϭ 3, P Ͻ 0.05), **P Ͻ 0.05 from untreated PPHN, *P Ͻ 0.05 from control. ulation of energy homeostasis. Because intracellular ATP modulates iHSP70 chaperone activity and SOD2-iHSP70 dissociation, decreased ATP levels may impair SOD-2 import. We directly quantified intracellular ATP, ADP, and AMP levels by HPLC in PAEC from control and PPHN lambs. Compared with control PAEC, ATP levels were lower and the levels of ADP and AMP were several times higher in PPHN PAEC (Fig. 8A) .
SOD2 degradation is increased in PPHN. Ubiquitin-proteasomal degradation pathways degrade many proteins in the cell. We hypothesized that impaired mitochondrial import predisposes SOD-2 to oxidative damage and increased degradation in PPHN to prevent accumulation of nonfunctional SOD-2. To test this hypothesis, we assessed the ubiquitination of SOD-2 in PAEC by immunoprecipitation. Poly-ubiquitinated SOD-2 was increased by approximately twofold in PPHN compared with control PAEC (Fig. 8B) . This suggests that increased ubiquitination is one of the mechanisms that degrades SOD-2 in PPHN-PAEC.
DISCUSSION
Our studies demonstrate that iHSP70 chaperones SOD-2 to the mitochondria, where dissociation of SOD2-iHSP70 complex appears to facilitate SOD-2 import into the mitochondrial matrix by mt-HSP70. Intracellular ATP appears to regulate these biologically important interactions for targeting SOD-2 to the mitochondria. Our study provides novel data that SOD-2 import to the mitochondria is impaired as a result of decreased mitochondrial ATP synthesis and contributes to mitochondrial oxidative stress in PPHN. Our study also provides a mechanism for decreased SOD-2 levels in the mitochondria of PPHN PAEC that we previously reported (2) . Although our previous study demonstrated that a decrease in SOD-2 levels contributes to increased mitochondrial oxidative stress in the PAEC, the mechanisms involved in decreased SOD-2 targeting to mitochondria remained unclear.
iHSP70 interacts with SOD-2 in the cytosol and targets SOD-2 to the mitochondria after its synthesis. Previous studies reported that short-term exercise induces SOD-2 protein and HSP70 expression in the left ventricles of young rats (39) . Our study provides novel data to establish an association between SOD-2 and iHSP70 as it relates to SOD-2 function in vascular endothelium. The biological role of SOD2-iHSP70 interaction in SOD-2 import was suggested by our studies involving interruption of this interaction. PFT-and iHSP70 knockdown separately disrupted SOD-2 transport to the mitochondria. Together, these data indicate that iHSP70 chaperones SOD-2 to the mitochondria. Previous studies have reported that the mitochondrial-targeting presequence on SOD-2 drives its mitochondrial import, and genetic polymorphism in this mitochondrial targeting sequence that results in substitution of alanine for valine slows the SOD-2 import and leads to its accumulation in the interspace between the OMM and IMM (47, 48) . The specific role of alterations in iHSP70-SOD2 interaction in diseases associated with oxidative stress requires further study. We used a fetal lamb model of PPHN induced by prenatal ductal constriction for our studies because it simulates a known mechanism for PPHN. This model also reproduces the hemodynamic and structural alterations observed in neonates with PPHN. However, our observations on alterations in SOD2-iHSP70 interaction from this model may not be directly extrapolated to neonates with PPHN.
The interaction between SOD-2 and iHSP70 in the cytosol is quite unique and differs from eNOS-HSP90 interaction, which increases eNOS activity (34) . Our observation specific to SOD2-iHSP70 association is that, in the cytosol, this association appears to increase SOD-2 transport to the mitochondria. However, at the OMM, SOD2-iHSP70 complex must dissociate to allow SOD-2 to dock to the translocon (TOM20) on the outer membrane, and this critical process is impaired in PPHN. The dissociation of iHSP70 at the OMM is the rate-limiting step for SOD-2 import and requires adequate intracellular ATP. It is believed that binding of ATP to HSP70 initiates a very fast "on-binding" and rapid release of client protein from the protein-binding domain of iHSP70 COOH terminus, whereas ADP slows the dissociation rate (3). Our studies demonstrate that intracellular ATP promotes SOD2-iHSP70 dissociation and facilitates SOD-2 import. We observed that lower intracellular ATP levels and elevated ADP levels in PPHN PAEC may contribute to the impaired SOD2-iHSP70 dissociation and SOD-2 import to the mitochondria. Persistently elevated ADP levels, coupled with lower ATP synthesis, indicate impaired coupling of oxidative phosphorylation and ATP synthesis in PPHN. In normal mitochondria, respiration and oxidative phosphorylation are coupled, and increases in ADP level would increase oxygen consumption (respiratory bursts or stage 3 respirations) and ultimately lead to increased ATP synthesis (11, 44) . The mechanism of changes in oxygen consumption and possible uncoupled respiration in PPHN remain unclear. Previous studies have shown that ROS are involved in the regulation of several cellular processes, including mitochondrial bioenergetics and cell death (12) . The addition of an oxidant to isolated mitochondria can uncouple the mitochondrial ATP production as a result of increased proton leak from the IMM (12, 22) . Because PPHN is associated with increased oxidative stress, we speculate that this leads to uncoupling of respiration and oxidative phosphorylation in PPHN. Oxidative phosphorylation Fig. 7 . Effects of ATP on SOD-2 interactions with chaperone in the cytosol and mitochondria of PAEC. iHSP70-SOD2 association in the cytosolic and mtHSP70-SOD2 in the mitochondrial fractions was assessed by immunoprecipitation, and the results are represented by the ratio of iHSP70 or mt-HSP70 to SOD-2. A: exogenous ATP (10 M) decreased iHSP70-SOD2 association after addition to cell lysates in the cytosolic fraction of PPHN PAEC (n ϭ 5, P Ͻ 0.05). B: in the mitochondrial fractions, exogenous ATP increased mtHSP70-SOD2 association in PPHN (n ϭ 4, P Ͻ 0.05). The effect of ATP on SOD-2 import was assessed by Western blots to quantify changes in SOD-2 protein level in the mitochondria after ATP treatment and corrected against proinhibitin-2, the loading control for mitochondrial protein. C: ATP increased SOD-2 levels in the mitochondria of PPHN PAEC (n ϭ 5, P Ͻ 0.05). D: incubation of control PAEC with 10 M oligomycin for 2 h decreased SOD-2 levels in the mitochondria when compared with ATP-treated samples and untreated controls (n ϭ 5, P Ͻ 0.05). #&P Ͻ 0.005 from control and oligomycin-treated control.
Ubiquitinated Fig. 8 . Coupling of mitochondrial respiration and ATP synthesis is depressed and increases SOD-2 degradation in PPHN. A: ATP levels were lower, and the levels of ADP and AMP were higher in PPHN-PAEC when compared with control PAEC (n ϭ 3, P Ͻ 0.05). #P Ͻ 0.05 from control. B: representative immunoblots of ubiqitinated SOD-2 and summary data for ratio of ubiquitinated to total SOD2 are shown for control and PPHN PAEC. SOD-2 degradation was assessed by quantifying ubiqitinated fraction of total SOD-2 protein by immunoprecipitation. Poly-ubiqitinated SOD-2 is higher in PPHN PAEC than controls (n ϭ 3, P Ͻ 0.05), #P Ͻ 0.05 from control. may be the "sensor" that signals increased SOD-2 import to reduce mitochondrial oxidative stress. SOD-2 activity is known to be induced by increased ROS generation (22) . Although increased mitochondrial O 2 ·Ϫ level is expected to stimulate SOD-2 import to remove the excess O 2 ·Ϫ , we previously reported that SOD-2 expression and activity are downregulated in the mitochondria in PPHN (2) . In the presence of oxidative stress in PPHN, ATP increased SOD-2 activity in a dose-dependent manner in the present study. Because mitochondrial oxidative stress can impair mitochondrial function and ATP synthesis, there appears to be coordinated regulation of these 2 processes in normal (control) PAEC.
Total SOD-2 activity is decreased in the lungs of PPHN lambs (10) . Adults with established pulmonary hypertension have decreased SOD-2 in their PA endothelium (28) . We previously reported that SOD-2 expression is decreased in both the cytosol and mitochondria of PPHN-PAEC (2). Studies in fawn-hooded rats with chronic idiopathic pulmonary hypertension showed epigenetic DNA hypermethylation of cytidinephosphate-guanosine islands at the promoter region of SOD-2, which leads to decreased SOD-2 expression in their endothelial cells (28, 29) . Our data indicate that increased degradation of SOD-2 in the cytosol of PPHN PAEC decreased the availability of SOD-2 for mitochondrial import. Our findings indicate that oxidative stress can damage unprocessed SOD-2 in the cytosol. Damaged SOD-2 is probably degraded by ubiquitinproteasomal degradation system and prevents aggregation diseases.
Increased mitochondrial ROS can affect diverse redox signaling pathways including ь NO-cGMP signaling. ь NO is an important mediator of pulmonary vasodilatation (48) . Extracellular ATP stimulates eNOS activity and increases the release of ь NO from PAEC (34) . However, efficient scavenging of mitochondrial O 2 ·Ϫ may be critical for Ṅ O availability and its role in the smooth muscle relaxation in blood vessels. We recently reported that overexpression of SOD-2 in the PA in PPHN decreased mitochondrial oxidative stress and increased eNOS function and PA vasodilatation (2) . In the present studies, disruption of mitochondrial import of SOD-2 by PFT-decreased the relaxation response of control PA to ATP (a NOS agonist) and SNAP (an NO donor). However, the relaxation response was improved by pretreatment of PA with mitochondrial O 2 ·Ϫ scavenger, Mito-Q at 10 Ϫ12 M concentration. Mito-Q was previously reported to increase superoxide levels through redox cycling at a concentration of 10 Ϫ9 -10 Ϫ6 M in bovine aortic endothelial cells and in isolated mitochondria (20, 22) . We, therefore, used Mito-Q at a 1,000-fold lower concentration than the levels observed to cause oxidative stress and demonstrated improved relaxation response of PA by Mito-Q. These data indicate that mitochondrial oxidative stress from impaired SOD-2 function attenuated the vasodilator responses when SOD-2 trafficking is inhibited. SOD-2 may play a key role in the regulation of eNOS function and vascular tone of the PA. Thus improving mitochondrial antioxidant function may be a viable adjunct to the current management of chronic pulmonary hypertension.
We conclude that iHSP70 chaperones SOD-2 to the mitochondria, a critical step in the regulation of mitochondrial oxidative stress. In PPHN, impaired coupling of mitochondrial respiration and ATP synthesis is associated with decreased SOD2-iHSP70 dissociation and SOD-2 import. This altered regulation appears to contribute to oxidative stress and impaired pulmonary vasodilation observed in this disease.
